Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NORTHROP GRUMMAN CORP /DE/ Director's Dealing 2019

Feb 15, 2019

29899_dirs_2019-02-15_1f65659e-3216-4036-b42b-a16f66b2da90.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NORTHROP GRUMMAN CORP /DE/ (NOC)
CIK: 0001133421
Period of Report: 2019-02-13

Reporting Person: CHESTON SHEILA C. (Corp. VP & General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-13 Common Stock M 10440.8500 $0.0000 Acquired 54136.3700 Direct
2019-02-13 Common Stock F 4519.0000 $0.0000 Disposed 49617.3700 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-13 Restricted Performance Stock Rights $ A 8075.8500 Acquired Common Stock (8075.8500) Direct
2019-02-13 Restricted Performance Stock Rights $ M 10440.8500 Disposed Common Stock (10440.8500) Direct
2019-02-13 Restricted Stock Rights $ A 2845.0000 Acquired Common Stock (2845.0000) Direct

Footnotes

F1: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/16 with a valuation of performance measurement period ("measurement period") that ended 12/31/18. RPSRs to be settled at 115% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2019.

F2: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e)

F3: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

F4: The RPSRs acquired include (i) 1,361.85 vested RPSRs with respect to the measurement period ended 12/31/18 acquired due to settlement of the 2016 RPSRs held at 115% of the target award and (ii) 6,714 unvested RPSRs granted under the LTISP on 2/13/19 with a measurement period ending on 12/31/21.

F5: Total amount includes 10,440.85 vested RPSRs granted under the LTISP on 2/17/16 with a measurement period ending on 12/31/18; 6,714 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 5,171 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; and 7,626 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19.

F6: Total amount includes 6,714 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 5,171 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; and 7,626 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19.

F7: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/13/19 and will vest on 2/13/22.

F8: Total amount includes 2,845 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 2,348 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; 3,189 RSRs granted under the LTISP on 2/17/17 that will vest on 2/17/20; and 4,120 RSRs granted under the LTISP on 2/17/16 that will vest on 2/17/19.